Lakeshore Biopharma CO., LTD. (LSBWF) SEC Filings — 2025
13 SEC filings for Lakeshore Biopharma CO., LTD. (LSBWF) in 2025.
Filings
- LakeShore Biopharma Agrees to Go Private — 6-K · Nov 4, 2025
- LakeShore Biopharma Transitions to OTC Market — 6-K · Sep 22, 2025
- LakeShore Biopharma Faces Nasdaq Delisting — 6-K · Sep 12, 2025
- LakeShore Biopharma Appoints New Independent Director — 6-K · Sep 10, 2025
- LakeShore Biopharma Receives Revised Offer — 6-K · Aug 28, 2025
- LakeShore Biopharma Files 6-K Amidst Preliminary Proposal — 6-K · Aug 18, 2025
- LakeShore Biopharma's Losses Widen Amid Revenue Dip, R&D Surge — 20-F · Jul 31, 2025
- LakeShore Biopharma Reports Change in Control — 6-K · Jul 15, 2025
- LakeShore Biopharma Files 6-K with Press Release — 6-K · Jul 8, 2025
- LakeShore Biopharma Director Resigns — 6-K · May 12, 2025
- LakeShore Biopharma Enters Financing Lease Agreement — 6-K · May 6, 2025
- LakeShore Biopharma Wins Court Dismissal of Former Chairman's Injunctions — 6-K · Mar 25, 2025
- LakeShore Biopharma Adopts Amended Share Incentive Plan — 6-K · Mar 12, 2025